NewEdge Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
74,002
+12,378
+20% +$998K 0.02% 687
2026
Q1
$4.36M Sell
61,624
-5,327
-8% -$399K 0.02% 752
2025
Q4
$5.29M Buy
66,951
+9,607
+17% +$760K 0.02% 635
2025
Q3
$4.72M Buy
57,344
+3,125
+6% +$246K 0.02% 654
2025
Q2
$4.36M Buy
54,219
+327
+0.6% +$25.2K 0.02% 620
2025
Q1
$4.33M Buy
53,892
+1,118
+2% +$93K 0.03% 558
2024
Q4
$4.32M Buy
52,774
+3,671
+7% +$305K 0.03% 546
2024
Q3
$4.05M Buy
49,103
+1,900
+4% +$142K 0.03% 549
2024
Q2
$3.31M Buy
47,203
+737
+2% +$52.6K 0.02% 570
2024
Q1
$3.44M Buy
46,466
+1,843
+4% +$128K 0.03% 507
2023
Q4
$2.97M Buy
44,623
+5,023
+13% +$314K 0.03% 517
2023
Q3
$2.49M Sell
39,600
-3,159
-7% -$197K 0.03% 530
2023
Q2
$2.42M Buy
42,759
+240
+0.6% +$13.3K 0.03% 532
2023
Q1
$2.45M Buy
42,519
+1,427
+3% +$96.3K 0.03% 470
2022
Q4
$767K Buy
41,092
+7,175
+21% +$514K 0.02% 608
2022
Q3
$2.06M Sell
33,917
-2,098
-6% -$134K 0.03% 420
2022
Q2
$2.26M Buy
36,015
+8,256
+30% +$547K 0.04% 412
2022
Q1
$1.95M Buy
27,759
+2,809
+11% +$190K 0.03% 426
2021
Q4
$1.56M Buy
24,950
+13,711
+122% +$861K 0.02% 540
2021
Q3
$694K Buy
11,239
+361
+3% +$21.7K 0.02% 655
2021
Q2
$651K Buy
10,878
+1,511
+16% +$95.8K 0.02% 657
2021
Q1
$569K Buy
9,367
+439
+5% +$24.2K 0.02% 626
2020
Q4
$419K Buy
8,928
+501
+6% +$21.7K 0.01% 668
2020
Q3
$313K Sell
8,427
-69
-0.8% -$2.62K 0.01% 703
2020
Q2
$310K Buy
8,496
+1,585
+23% +$55.2K 0.01% 665
2020
Q1
$211K Sell
6,911
-11,418
-62% -$506K 0.01% 692
2019
Q4
$934K Buy
18,329
+3,946
+27% +$190K 0.04% 365
2019
Q3
$678K Buy
14,383
+1,825
+15% +$87K 0.03% 417
2019
Q2
$624K Sell
12,558
-884
-7% -$41.6K 0.04% 355
2019
Q1
$572K Buy
13,442
+5,076
+61% +$224K 0.04% 368
2018
Q4
$344K Sell
8,366
-1,512
-15% -$64.9K 0.02% 455
2018
Q3
$462K Buy
9,878
+3,700
+60% +$169K 0.04% 380
2018
Q2
$269K Buy
6,178
+1,506
+32% +$70.2K 0.02% 437
2018
Q1
$210K Sell
4,672
-3,205
-41% -$156K 0.02% 459
2017
Q4
$409K Buy
7,877
+319
+4% +$16.8K 0.06% 262
2017
Q3
$400K Buy
7,558
+3,267
+76% +$159K 0.06% 236
2017
Q2
$214K Sell
4,291
-70
-2% -$3.25K 0.04% 309
2017
Q1
$203K Sell
4,361
-155
-3% -$7.39K 0.05% 254
2016
Q4
$217K Buy
+4,516
New +$207K 0.06% 229

Other funds holding MET

NewEdge Advisors's MET Position: Q2 2026 in Review

NewEdge Advisors increased its MetLife (MET) stake by 20% in Q2 2026, buying an estimated $998K and bringing the position to 74,002 shares worth $6.26M. The position accounts for 0.02% of the portfolio, ranked #687.

NewEdge Advisors first reported a position in MET in Q4 2016 and has held it in 39 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • NewEdge Advisors held 74,002 shares of MetLife worth $6.26M as of Q2 2026.
  • NewEdge Advisors bought 12,378 MetLife shares in Q2 2026, an estimated $998K.
  • MetLife made up 0.02% of NewEdge Advisors's portfolio in Q2 2026, its #687 holding.
  • NewEdge Advisors first reported a position in MetLife in Q4 2016 and has held it in 39 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.